109 related articles for article (PubMed ID: 15848607)
41. Prevalence and severity of anemia in pediatric hemodialysis patients.
Azhir A; Nasiri J; Gheisari A
Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
[TBL] [Abstract][Full Text] [Related]
42. Correlation between post kidney transplant anemia and kidney graft function.
Iwamoto H; Nakamura Y; Konno O; Hama K; Yokoyama T; Kihara Y; Kawachi S; Shimazu M
Transplant Proc; 2014; 46(2):496-8. PubMed ID: 24655998
[TBL] [Abstract][Full Text] [Related]
43. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
44. Evolution of the renal function is a better predictor of long-term survival than serum creatinine.
Marqués GG; Goenaga PE; Royo FJ; Escolá JM; García Fernández N; Unanua AP
Transplant Proc; 2005 Nov; 37(9):3701-4. PubMed ID: 16386511
[TBL] [Abstract][Full Text] [Related]
45. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
46. Pediatric renal transplantation: Clinical analysis of 28 cases.
Berber I; Tellioglu G; Yigit B; Turkmen F; Titiz MI; Altaca G
Transplant Proc; 2006 Mar; 38(2):430-1. PubMed ID: 16549139
[TBL] [Abstract][Full Text] [Related]
47. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
Tanvetyanon T; Choudhury AM
Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
[TBL] [Abstract][Full Text] [Related]
48. Predictive factors for chronic renal failure one year after orthotopic liver transplantation.
Guitard J; Ribes D; Kamar N; Muscari F; Cointault O; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
Ren Fail; 2006; 28(5):419-25. PubMed ID: 16825092
[TBL] [Abstract][Full Text] [Related]
49. Elderly donor kidney transplant: factors involved in graft survival.
Cacho DT; Cusí LI; Piqué AA; Villar PB; Reyes LI; Alvarez-Vijande García R; Salinas FO; del Pozo RG
Transplant Proc; 2005 Nov; 37(9):3690-2. PubMed ID: 16386507
[TBL] [Abstract][Full Text] [Related]
50. Perioperative erythropoietin efficacy in renal transplantation.
Mohiuddin MK; El-Asir L; Gupta A; Brown A; Torpey N; Ward M; Talbot D; Ahmed S
Transplant Proc; 2007; 39(1):132-4. PubMed ID: 17275489
[TBL] [Abstract][Full Text] [Related]
51. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
52. Similar impact of slow and delayed graft function on renal allograft outcome and function.
Rodrigo E; Fernández-Fresnedo G; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Zubimendi JA; De Francisco AL; Sanz de Castro S; Arias M
Transplant Proc; 2005 Apr; 37(3):1431-2. PubMed ID: 15866627
[TBL] [Abstract][Full Text] [Related]
53. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
[TBL] [Abstract][Full Text] [Related]
54. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
55. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
[TBL] [Abstract][Full Text] [Related]
56. Role of erythropoietin in anemia after heart transplantation.
Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for the development of delayed graft function in deceased donor renal transplants.
Jushinskis J; Trushkov S; Bicans J; Suhorukov V; Shevelev V; Ziedina I; Rozental R
Transplant Proc; 2009 Mar; 41(2):746-8. PubMed ID: 19328971
[TBL] [Abstract][Full Text] [Related]
58. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
[TBL] [Abstract][Full Text] [Related]
59. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
Ritz E; Laville M; Bilous RW; O'Donoghue D; Scherhag A; Burger U; de Alvaro F;
Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors for anemia within the first year after orthotopic liver transplantation.
Guitard J; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Perron JM; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2342-5. PubMed ID: 16980085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
